Mediniche, Inc. – Trademark Portfolio
Entity Type: 03
Mediniche, Inc. holds 29 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 22 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 4 Nice Classification classes. Currently, 13 trademarks are registered and 1 is pending. Notable registered marks include LASINE, B-NATAL, FEMTABS, OCULASH, and OCUSTAT. The owner is based in St. Louis, MO.
215 Dunn Road
St. Louis, MO 63031
Showing of trademarks Trademarks
Trademark Classifications
Mediniche, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Mediniche, Inc. have?
Mediniche, Inc. has 29 U.S. trademarks filed with the USPTO. Of these, 13 registered, 1 pending, 13 abandoned, 2 cancelled.
What trademark classes does Mediniche, Inc. file in?
Mediniche, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services), Class 21 (Housewares). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Mediniche, Inc.'s most well-known trademarks?
Mediniche, Inc.'s registered trademark portfolio includes well-known marks such as LASINE, B-NATAL, FEMTABS, OCULASH, and OCUSTAT. These are among 13 currently registered trademarks in the portfolio.
What is Mediniche, Inc.'s trademark registration success rate?
Mediniche, Inc. has a 46% trademark registration rate, with 13 out of 28 resolved applications resulting in successful registration. Currently, 1 application is pending review.